They included HL60 acute myeloid leukemia (AML) cells [21], NCI-H446 lung cancer cells [34], TT and TE-8 esophageal cancer cells [41], SNU-005 and SNU-484 gastric cancer cells [40] HuT-78 CD4+ T-cells [64], 184FMY2 and 184B5 HMECs [20], LNCaP prostate cancer cells [48], PC-3M-1E8 and PC-3M-2B4 (2B4) prostate cancer cells [86], and SKOV3 and A2780 ovarian cancer cells [7]. This evidence concerns the gene CD4 and prostate carcinoma.